Kronos Bio Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in Oncology

January 9, 2023

https://www.globenewswire.com/news-release/2023/01/09/2585048/0/en/Kronos-Bio-Announces-Discovery-Collaboration-with-Genentech-to-Advance-Novel-Therapies-Against-Transcriptional-Targets-in-Oncology.html

Kronos Bio will receive a $20 million upfront payment and could receive up to an additional $554 million in milestone payments

Agreement will leverage Kronos Bio’s expertise in transcriptional regulatory networks and its proprietary drug discovery platform

Read more at globenewswire.com

Related news for (KRON)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.